海洋功能性成分

源自海洋的多糖、蛋白质与氨基酸

46 项原料.

关于本类别

Marine functional ingredients sourced from Japan's surrounding waters constitute one of the most clinically validated and commercially mature categories in the global functional supply chain. From Hokkaido salmon nasal cartilage proteoglycan to Okinawan mozuku-derived fucoidan and Yaeyama-grown astaxanthin, Japanese marine actives are anchored in decades of academic research at Hokkaido University, the University of the Ryukyus, and Tokai University, supported by industrial fishery infrastructure that produces some of the cleanest marine biomass in the world. Market size for marine functional ingredient exports from Japan is estimated at USD 600–800 million annually (industry estimate, 2024–2026), with growth concentrated in joint-health proteoglycan, anti-inflammatory fucoidan, and skin-protective astaxanthin segments.

Historically, marine-derived nutrition has been embedded in Japanese diet for over a millennium: konbu kelp dashi, wakame seaweed soup, mozuku vinegar salads, and small dried fish (jako, niboshi) provide a continuous dietary baseline of marine peptides, polysaccharides, and trace minerals. The industrialization of these traditions began in the post-war era when Hokkaido and Tohoku fisheries sought higher-value uses for by-products. Salmon nasal cartilage — historically discarded — became the global benchmark source of high-purity proteoglycan after Hirosaki University researchers developed an extraction process in the 2000s that yields Type II collagen-bound proteoglycan at clinically relevant purity. Fucoidan from Okinawan mozuku (Cladosiphon okamuranus) was similarly commercialized after University of the Ryukyus studies in the 1990s established its anti-inflammatory and immune-modulatory profile. Astaxanthin, originally derived from krill, is now produced industrially in Japan from Haematococcus pluvialis microalgae cultivated in Okinawa and Kagoshima, with Fuji Chemical Industries' AstaReal brand recognized as a global category leader.

The contemporary supplier landscape is led by Fuji Chemical Industries (astaxanthin), Maruha Nichiro (marine peptides, oils, proteoglycan), Nippon Suisan / Nissui (omega-3 EPA/DHA, marine peptides), Kaneka (CoQ10, marine actives), Kibun Foods (surimi-derived peptides), South Product (Okinawa-based fucoidan), Marudai Food, and Yaeyama Shokusan (astaxanthin and chlorella). Most operate FSSC 22000 and ISO 9001 certified facilities, with many also holding GMP-equivalent supplement certifications, halal certification, and patents on their extraction technologies. Many of these ingredients carry FFC (Foods with Function Claims) status — fucoidan for digestive health, proteoglycan for joint mobility, astaxanthin for eye fatigue and skin elasticity — providing OEM buyers with pre-validated efficacy claims.

For overseas buyers, the typical OEM flow involves identifying the bioactive concentration required (e.g. 60% fucoidan, 5% natural astaxanthin), confirming the extraction solvent and any residual carrier oils, and validating sustainability documentation (MSC, ASC, or Friend of the Sea certification is increasingly requested by EU buyers). MOQs range from 5–10 kg for premium proteoglycan and astaxanthin oleoresin to 500+ kg for fucoidan and marine collagen. Buyers should verify the species and harvest location (especially for fucoidan, where mozuku, mekabu, and gagome kombu yield biochemically distinct molecules), and confirm allergen status — fish-derived collagen and proteoglycan are not always declared as allergens in Japan but must be in the EU and US. Related categories include Cosmetic Raw Materials (for marine collagen and fish-skin actives used in skincare), Food Ingredients (for konbu, wakame, and bonito-derived umami), and Okinawan Longevity Ingredients (for mozuku and umi-budo).

关键事实

Market position
Japan exports an estimated USD 600–800 million of marine functional ingredients annually (industry estimate, 2024–2026); Fuji Chemical Industries' AstaReal is recognized as a global astaxanthin category leader with patents on natural Haematococcus-derived production.
Heritage
Konbu kelp dashi has been documented in Japanese cuisine since the Muromachi period; mozuku and wakame consumption in Okinawa predates the Ryukyu Kingdom era; modern functional applications were industrialized between the 1990s and 2010s following university-led research.
Differentiation vs Korean / Chinese competitors
Japanese suppliers offer clinically validated FFC-notified actives, single-species traceability (e.g. Cladosiphon okamuranus mozuku, Haematococcus pluvialis astaxanthin), and patent-backed extraction processes that yield substantially higher purity than commodity Chinese or Korean alternatives.
Certifications
FSSC 22000, ISO 9001, MSC/ASC, Friend of the Sea, Halal, Kosher, FFC notification with the Consumer Affairs Agency; many suppliers hold pharmaceutical-grade GMP certification for supplement-channel materials.
Notable ingredients
Salmon nasal cartilage proteoglycan, Okinawan mozuku fucoidan, natural astaxanthin from Haematococcus pluvialis, marine collagen tripeptides, EPA/DHA from Hokkaido sardine and pollock, scallop-derived peptides, and fish-skin elastin.

从这里开始

针对首次浏览本类别的访客的编辑精选。

法规概览

Marine functional ingredients face overlapping food, supplement, and cosmetic regulations depending on end-use. Within Japan, joint and immune claims are commonly registered as FFC, while pharmacological claims require quasi-drug or pharmaceutical pathways. EU buyers should screen Japanese marine actives against the Novel Food Catalogue: fucoidan in oral supplement form was assessed as novel in 2017 and requires EFSA-approved sources for new launches, while marine collagen peptides are generally accepted with safety documentation. US buyers should verify FDA NDIN (New Dietary Ingredient Notification) status for any active without prior US market history, and confirm self-affirmed GRAS for food applications. Allergen disclosure is critical: fish-derived collagen, proteoglycan, and elastin are mandatory allergens in the EU and Canada, recommended-list allergens in Japan, and require 'fish' declaration on US labels. Sustainability documentation is increasingly demanded by EU and UK retailers — buyers should ask for MSC chain-of-custody for wild-harvested species and ASC for farmed inputs; for seaweed-derived ingredients, ASC-MSC Seaweed Standard certification is the emerging benchmark. China NMPA Blue Hat applications for marine functional ingredients require 12–24 months and substantial dossiers.

OEM 采购方常见问题

Q. 日本海洋功能性原料(fucoidan、mozuku、蛋白聚糖)在全球具备竞争力的原因是什么?

日本主导海洋生物活性R&D,特别是在fucoidan(kombu/mozuku来源的硫酸化多糖)、冲绳产fucoidan丰富mozuku,以及鲑鱼鼻软骨蛋白聚糖方面。这些有多项FFC备案,且见诸已发表的同行评议研究。许多专属于日本生产。

信息来源

  • CAA — Foods with Function Claims database (proteoglycan, fucoidan)
  • PubMed — fucoidan and proteoglycan clinical research
Q. 自2011年福岛事件以来,日本海洋原料是否进行辐射检测?

是的。自2011年起,日本所有主要海洋原料供应商均标准提供辐射检测证书。大多数产品来自北海道、冲绳或日本西部(九州、四国)——远离2011年受影响区域——并常规检测低于欧盟/美国/中国进口限值。COA含辐射检测结果是标准做法。

信息来源

  • MHLW — Food radioactivity standards
  • Japan Fisheries Agency monitoring program
Q. fucoidan提取物或蛋白聚糖的典型MOQ是多少?

fucoidan和蛋白聚糖等高端海洋活性成分通常样品起订1–5 kg,商业订单起订10–25 kg。价格较高(¥10,000–50,000/kg范围),反映出低产率及专有提取工艺。研发量通常可获得。

信息来源

  • Industry knowledge — Japanese marine ingredient suppliers

行业知识陈述 — 尚未锁定单一一手信源

Q. 日本海洋原料能否用于纯素产品?

植物来源的海洋原料(kombu、mozuku来源的fucoidan、海葡萄提取物)属于纯素。动物来源的海洋原料(鲑鱼蛋白聚糖、鲨鱼软骨硫酸软骨素、牡蛎珍珠提取物)则不属于。在为纯素定位产品配方前,请确认来源生物。

信息来源

  • Industry knowledge — Japanese marine ingredient classification

行业知识陈述 — 尚未锁定单一一手信源